Annual EBIT
-$42.61 M
+$26.11 M+38.00%
December 31, 2023
Summary
- As of February 7, 2025, VINC annual earnings before interest & taxes is -$42.61 million, with the most recent change of +$26.11 million (+38.00%) on December 31, 2023.
- During the last 3 years, VINC annual EBIT has fallen by -$31.89 million (-297.69%).
- VINC annual EBIT is now -297.69% below its all-time high of -$10.71 million, reached on December 31, 2020.
Performance
VINC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$7.79 M
-$427.00 K-5.80%
September 30, 2024
Summary
- As of February 7, 2025, VINC quarterly earnings before interest & taxes is -$7.79 million, with the most recent change of -$427.00 thousand (-5.80%) on September 30, 2024.
- Over the past year, VINC quarterly EBIT has dropped by -$2.26 million (-40.85%).
- VINC quarterly EBIT is now -194725.00% below its all-time high of -$4000.00, reached on March 31, 2020.
Performance
VINC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$28.17 M
+$1.82 M+6.06%
September 30, 2024
Summary
- As of February 7, 2025, VINC TTM earnings before interest & taxes is -$28.17 million, with the most recent change of +$1.82 million (+6.06%) on September 30, 2024.
- Over the past year, VINC TTM EBIT has increased by +$14.44 million (+33.89%).
- VINC TTM EBIT is now -704150.00% below its all-time high of -$4000.00, reached on March 31, 2020.
Performance
VINC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VINC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.0% | -40.9% | +33.9% |
| 3 y3 years | -297.7% | +64.0% | +62.3% |
| 5 y5 years | - | - | - |
VINC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.0% | -40.9% | +64.0% | at high | +62.8% |
| 5 y | 5-year | -297.7% | +38.0% | <-9999.0% | +64.0% | <-9999.0% | +62.8% |
| alltime | all time | -297.7% | +38.0% | <-9999.0% | +64.0% | <-9999.0% | +62.8% |
Vincerx Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.79 M(+5.8%) | -$28.17 M(-6.1%) |
| Jun 2024 | - | -$7.37 M(-1.5%) | -$29.99 M(-13.5%) |
| Mar 2024 | - | -$7.48 M(+35.2%) | -$34.68 M(-18.6%) |
| Dec 2023 | -$42.61 M(-38.0%) | -$5.53 M(-42.4%) | -$42.61 M(-15.0%) |
| Sep 2023 | - | -$9.61 M(-20.3%) | -$50.12 M(-10.7%) |
| Jun 2023 | - | -$12.06 M(-21.7%) | -$56.10 M(-10.2%) |
| Mar 2023 | - | -$15.41 M(+18.2%) | -$62.50 M(-9.0%) |
| Dec 2022 | -$68.72 M | -$13.04 M(-16.4%) | -$68.72 M(-6.4%) |
| Sep 2022 | - | -$15.59 M(-15.6%) | -$73.39 M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$18.46 M(-14.6%) | -$75.73 M(+1.4%) |
| Mar 2022 | - | -$21.63 M(+22.1%) | -$74.66 M(+19.2%) |
| Dec 2021 | -$62.66 M(+484.8%) | -$17.71 M(-1.2%) | -$62.66 M(+13.3%) |
| Sep 2021 | - | -$17.93 M(+3.1%) | -$55.32 M(+46.8%) |
| Jun 2021 | - | -$17.39 M(+80.7%) | -$37.70 M(+85.4%) |
| Mar 2021 | - | -$9.63 M(-7.2%) | -$20.34 M(+89.8%) |
| Dec 2020 | -$10.71 M | -$10.37 M(+3300.7%) | -$10.71 M(+3032.7%) |
| Sep 2020 | - | -$305.00 K(+824.2%) | -$342.00 K(+824.3%) |
| Jun 2020 | - | -$33.00 K(+725.0%) | -$37.00 K(+825.0%) |
| Mar 2020 | - | -$4000.00 | -$4000.00 |
FAQ
- What is Vincerx Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Vincerx Pharma?
- What is Vincerx Pharma annual EBIT year-on-year change?
- What is Vincerx Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Vincerx Pharma?
- What is Vincerx Pharma quarterly EBIT year-on-year change?
- What is Vincerx Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Vincerx Pharma?
- What is Vincerx Pharma TTM EBIT year-on-year change?
What is Vincerx Pharma annual earnings before interest & taxes?
The current annual EBIT of VINC is -$42.61 M
What is the all time high annual EBIT for Vincerx Pharma?
Vincerx Pharma all-time high annual earnings before interest & taxes is -$10.71 M
What is Vincerx Pharma annual EBIT year-on-year change?
Over the past year, VINC annual earnings before interest & taxes has changed by +$26.11 M (+38.00%)
What is Vincerx Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of VINC is -$7.79 M
What is the all time high quarterly EBIT for Vincerx Pharma?
Vincerx Pharma all-time high quarterly earnings before interest & taxes is -$4000.00
What is Vincerx Pharma quarterly EBIT year-on-year change?
Over the past year, VINC quarterly earnings before interest & taxes has changed by -$2.26 M (-40.85%)
What is Vincerx Pharma TTM earnings before interest & taxes?
The current TTM EBIT of VINC is -$28.17 M
What is the all time high TTM EBIT for Vincerx Pharma?
Vincerx Pharma all-time high TTM earnings before interest & taxes is -$4000.00
What is Vincerx Pharma TTM EBIT year-on-year change?
Over the past year, VINC TTM earnings before interest & taxes has changed by +$14.44 M (+33.89%)